157 related articles for article (PubMed ID: 33046228)
1. Steatohepatitic hepatocellular carcinoma: imaging findings with clinicopathological correlation.
Inui S; Kondo H; Tanahashi Y; Fukukura Y; Sano K; Morisaka H; Saito K; Kondo F; Fukusato T; Furui S; Oba H
Clin Radiol; 2021 Feb; 76(2):160.e15-160.e25. PubMed ID: 33046228
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.
Shibahara J; Ando S; Sakamoto Y; Kokudo N; Fukayama M
Histopathology; 2014 Jun; 64(7):951-62. PubMed ID: 24898917
[TBL] [Abstract][Full Text] [Related]
3. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
Yeh MM; Liu Y; Torbenson M
Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
[TBL] [Abstract][Full Text] [Related]
4. Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI.
Min JH; Kang TW; Kim YY; Cha DI; Kim YK; Kim SH; Sinn DH; Ha SY; Kim K
Eur Radiol; 2021 May; 31(5):3315-3325. PubMed ID: 33159576
[TBL] [Abstract][Full Text] [Related]
5. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
6. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
7. Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics.
Park JH; Park YN; Kim MJ; Park MS; Choi JY; Chung YE; Rhee H
Liver Int; 2023 Jun; 43(6):1332-1344. PubMed ID: 37088983
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological assessment of steatohepatitic hepatocellular carcinoma.
Yamaoka K; Saitoh S; Kinowaki K; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki F; Suzuki Y; Arase Y; Ikeda K; Fukusato T; Kumada H
Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101799. PubMed ID: 34500120
[TBL] [Abstract][Full Text] [Related]
9. Imaging and prognostic characterization of fat-containing hepatocellular carcinoma subtypes.
Faure A; Dioguardi Burgio M; Cannella R; Sartoris R; Bouattour M; Hobeika C; Cauchy F; Trapani L; Beaufrère A; Vilgrain V; Ronot M
Radiol Med; 2024 May; 129(5):687-701. PubMed ID: 38512627
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis.
Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060
[TBL] [Abstract][Full Text] [Related]
11. Pathological overview of steatohepatitic hepatocellular carcinoma in a surgical series.
Trapani L; Beaufrère A; Hobeika C; Codjia T; Albuquerque M; Bouattour M; Lesurtel M; Cauchy F; Paradis V
Histopathology; 2023 Oct; 83(4):526-537. PubMed ID: 37222200
[TBL] [Abstract][Full Text] [Related]
12. Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India.
Jain D; Nayak NC; Kumaran V; Saigal S
Arch Pathol Lab Med; 2013 Jul; 137(7):961-6. PubMed ID: 23808468
[TBL] [Abstract][Full Text] [Related]
13. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
Kim SS; Kim SH; Song KD; Choi SY; Heo NH
J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
15. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
16. Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
Najmi Varzaneh F; Pandey A; Aliyari Ghasabeh M; Shao N; Khoshpouri P; Pandey P; Zarghampour M; Fouladi D; Liddell R; Anders RA; Kamel IR
Eur Radiol; 2018 Jul; 28(7):3032-3040. PubMed ID: 29383518
[TBL] [Abstract][Full Text] [Related]
17. Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.
Lee SE; An C; Hwang SH; Choi JY; Han K; Kim MJ
Eur Radiol; 2018 Apr; 28(4):1551-1559. PubMed ID: 29134355
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
[TBL] [Abstract][Full Text] [Related]
19. Steatohepatitis-like Changes in Focal Nodular Hyperplasia, A Finding to Distinguish From Steatohepatitic Variant of Hepatocellular Carcinoma.
Deniz K; Moreira RK; Yeh MM; Ferrell LD
Am J Surg Pathol; 2017 Feb; 41(2):277-281. PubMed ID: 28079599
[TBL] [Abstract][Full Text] [Related]
20. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase.
Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Okada A; Sugiura T; Tomoda K; Narumi Y; Nakamura H
J Comput Assist Tomogr; 2002; 26(6):981-7. PubMed ID: 12488747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
